Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Catheter Precision (VTAK) Deferred Taxes (2024 - 2025)

Catheter Precision (VTAK) has disclosed Deferred Taxes for 2 consecutive years, with -$247000.0 as the latest value for Q4 2025.

  • Quarterly Deferred Taxes fell 108.1% to -$247000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$1.8 million through Dec 2025, changed N/A year-over-year, with the annual reading at -$1.8 million for FY2025, 160.43% down from the prior year.
  • Deferred Taxes for Q4 2025 was -$247000.0 at Catheter Precision, down from $78000.0 in the prior quarter.
  • The five-year high for Deferred Taxes was $3.0 million in Q4 2024, with the low at -$950000.0 in Q2 2025.